Ajanta Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,421.64 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.40 per cent from ₹1,374.84 crore. This corresponds to a year-on-year *(YoY) growth of 21.47 per cent.
Operating Profit
Operating Profit stands at ₹333.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.77 per cent from ₹382.24 crore. This corresponds to a year-on-year *(YoY) growth of 12.20 per cent.
PBDT
PBDT stands at ₹392.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.39 per cent from ₹402.11 crore. This corresponds to a year-on-year *(YoY) growth of 26.94 per cent.
Profit Before Tax
Profit Before Tax stands at ₹347.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.20 per cent from ₹358.60 crore. This corresponds to a year-on-year *(YoY) growth of 28.84 per cent.
Net Profit
Net Profit stands at ₹266.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.58 per cent from ₹273.77 crore. This represents a 18.40 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Ajanta Pharma Ltd News
Ajanta Pharma Ltd Earnings
- YOY
- QOQ
Ajanta Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Ajanta Pharma Ltd Research Reports
Ajanta Pharma Ltd Financial Reports
Ajanta Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -0.67% | -2.83% | 11.98% | 22.71% | 16.57% | 25.26% |
| Abbott India | 0.70% | 1.63% | 0.22% | 0.73% | -9.28% | -24.98% |
| Ipca Labs. | 3.45% | 4.62% | 8.08% | 23.55% | 17.64% | 22.26% |
| Anthem Bioscienc | -0.21% | -0.05% | -0.49% | 15.35% | 17.39% | 5.39% |
| Gland Pharma | -0.34% | -0.92% | 9.47% | 43.56% | 44.02% | 31.18% |
| Glaxosmi. Pharma | -0.96% | -2.37% | 9.58% | 2.64% | -2.65% | -27.09% |
| J B Chemicals & | 1.70% | 2.96% | 8.80% | 20.51% | 22.17% | 44.80% |
Company Info
Company Information
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah